This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Atul Ingle: Innovator in Cardiac Imaging Technology
Introduction
Atul Ingle is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of cardiac imaging technology. His innovative work focuses on enhancing the evaluation of cardiac infarction through advanced imaging techniques.
Latest Patents
Atul Ingle holds a patent for the "Evaluation of cardiac infarction by real time ultrasonic strain imaging." This patent describes a method for real-time strain imaging by acquiring a sequence of cardiac image frames. The technique estimates tissue displacement in the myocardium over a heart cycle using speckle tracking. The displacements are then used to calculate strain values, which are represented in a color map. This color map is warped to fit the myocardium in each image frame during the next heart cycle, providing a real-time overlay that enhances the visualization of cardiac function.
Career Highlights
Atul Ingle is associated with Koninklijke Philips Corporation N.V., a leading company in health technology. His work at Philips emphasizes the integration of innovative imaging solutions in medical diagnostics. His contributions have the potential to improve patient outcomes by providing more accurate assessments of cardiac conditions.
Collaborations
Atul has collaborated with notable colleagues, including Abhay Vijay Patil and Karl Erhard Thiele. These collaborations have fostered a productive environment for innovation and development in cardiac imaging technologies.
Conclusion
Atul Ingle's work in real-time ultrasonic strain imaging represents a significant advancement in cardiac diagnostics. His innovative approach has the potential to transform how cardiac infarctions are evaluated, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
